Novartis Pharma Exits from Pakistan – Asrar Qureshi’s Blog Post 1183
Novartis Pharma Exits from Pakistan – Asrar Qureshi’s Blog Post 1183 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1183 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Preamble This blog post summarizes the facts around the transaction, analyzing likely benefits and risks, and offering practical takeaways. Novartis Pakistan sold to IIL (Getz Group affiliate): what it means for the industry, patients and policy In May 2025 Novartis announced an agreement for its Pakistan business to be transferred to International Investment II Limited (IIL), an investment holding company affiliated with Muller & Phipps and part of the Getz Group, and in November 2025 Pakistan’s Competition Commission (CCP) completed a Phase-I review and authorized the transaction. The deal transfers control of Novartis Pharma (Pakistan) Limited fr...